Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Biomed Nanotechnol ; 10(8): 1599-609, 2014 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-25016659

RESUMO

Tacrolimus is widely used in the prophylaxis of solid-organ transplant rejection. Several studies have reported that tacrolimus has variable and poor bioavailability after oral administration, apart from adverse effects such as gastrointestinal disorders, hyperglycemia, nephro- and neurotoxicity. The aim of this work was to encapsulate tacrolimus (TAC) in lipid-core nanocapsules (LNC) as an oral strategy to deliver the drug. To validate our hypothesis, the pharmacodynamic effect of TAC-LNC was determined after oral and intraperitoneal (i.p.) administrations to mice. TAC-LNC had z-average diameter of 210 nm (unimodal), and 99.5% of encapsulation efficiency. In vitro sustained release was determined for TAC-LNC fitting an anomalous transport mechanism (n = 0.8). TAC-LNC demonstrated higher immunosuppressive activity after oral and i.p. administrations, when compared to the drug solution. TAC-LNC administered at 6.0 mg kg(-1) day(-1) showed equivalent percent reduction in lymphocyte when both routes of administration were used. After oral administration, drug nanoencapsulation allows reducing the dose by at least 40%. Furthermore, the nanoencapsulation of TAC in lipid-core nanocapsules showed pharmacodynamic effect similar for the oral and the i.p. routes. In conclusion, the lipid-core nanocapsules were able to improve the TAC deliver across the oral absorption barrier.


Assuntos
Imunossupressores/farmacologia , Lipídeos/farmacologia , Nanocápsulas/química , Tacrolimo/farmacologia , Administração Oral , Animais , Peso Corporal/efeitos dos fármacos , Imunossupressores/administração & dosagem , Imunossupressores/química , Imunossupressores/farmacocinética , Infusões Parenterais , Lipídeos/administração & dosagem , Lipídeos/química , Linfócitos/citologia , Linfócitos/efeitos dos fármacos , Masculino , Camundongos , Nanocápsulas/administração & dosagem , Tacrolimo/administração & dosagem , Tacrolimo/química , Tacrolimo/farmacocinética
2.
Drug Dev Ind Pharm ; 40(8): 1011-20, 2014 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23672183

RESUMO

Spray drying is a technique used to produce solid particles from liquid solutions, emulsions or suspensions. Buchi Labortechnik developed the latest generation of spray dryers, Nano Spray Dryer B-90. This study aims to obtain, directly, submicron drug particles from an organic solution, employing this equipment and using dexamethasone as a model drug. In addition, we evaluated the influence of both the type of solvent and surfactant on the properties of the powders using a 3(2) full factorial analysis. The particles were obtained with high yields (above 60%), low water content (below 2%) and high drug content (above 80%). The surface tension and the viscosity were strongly influenced by the type of solvent. The highest powder yields were obtained for the highest surface tension and the lowest viscosity of the drug solutions. The use of ionic surfactants led to higher process yields. The laser diffraction technique revealed that the particles deagglomerate into small ones with submicrometric size, (around 1 µm) that was also observed by scanning electron microscopy. Interaction between the raw materials in the spray-dried powders was verified by calorimetric analysis. Thus, it was possible to obtain dexamethasone submicrometric particles by vibrational atomization from organic solution.


Assuntos
Dexametasona/química , Solventes/química , Tensoativos/química , Tecnologia Farmacêutica/métodos , Excipientes/química , Microscopia Eletrônica de Varredura/métodos , Tamanho da Partícula , Pós/química , Soluções/química , Propriedades de Superfície , Tensão Superficial , Viscosidade
3.
J Nanosci Nanotechnol ; 13(12): 8144-53, 2013 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-24266207

RESUMO

In this study we developed a new drug delivery system for olanzanpine comprised of drug-loaded lipid-core nanocapsules incorporated in a thermosensitive hydrogel, intended to sustain the drug release. Firstly, olanzapine, a hydrophobic drug, was loaded in poly(epsilon-caprolactone) lipid core nanocapsules prepared by interfacial deposition of preformed polymer. The effects of the presence of ethanol and the amounts of sorbitan monostearate and medium-chain triglycerides on the particle size, zeta potential, polydispersity index, presence of microparticles and encapsulation efficiency were investigated using a 2(3) factorial design. The optimized nanocapsules were incorporated into a hydrophilic polymer (Poloxamer 407) dispersion in order to obtain a thermosensitive gel. The formulation containing 0.077 g of sorbitan monostearate, 0.22 ml of medium-chain triglycerides, 3 ml of ethanol and 18% of the thermosensitive polymer was selected according to the physicochemical properties. The rheology and release profiles of the mixed hydrophobic and hydrophilic delivery system were successfully characterized and revealed its great potential for the administration of hydrophobic drugs such as olanzapine with sustained in situ drug release.


Assuntos
Benzodiazepinas/química , Lipídeos/química , Nanocápsulas/química , Reologia , Olanzapina , Tamanho da Partícula , Poloxâmero/química , Poliésteres/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...